Farzin Haque
Stock Analyst at Jefferies
(2.73)
# 1,834
Out of 5,123 analysts
4
Total ratings
50%
Success rate
60.56%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Farzin Haque
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLMD Relmada Therapeutics | Initiates: Buy | $9 | $3.65 | +146.58% | 1 | Dec 22, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $5.86 | +70.65% | 1 | Sep 30, 2025 | |
| PYXS Pyxis Oncology | Assumes: Buy | $10 | $1.51 | +562.25% | 1 | May 7, 2024 | |
| VERA Vera Therapeutics | Upgrades: Buy | $18 → $26 | $42.74 | -39.17% | 1 | Nov 10, 2023 |
Relmada Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $9
Current: $3.65
Upside: +146.58%
Nuvation Bio
Sep 30, 2025
Initiates: Buy
Price Target: $10
Current: $5.86
Upside: +70.65%
Pyxis Oncology
May 7, 2024
Assumes: Buy
Price Target: $10
Current: $1.51
Upside: +562.25%
Vera Therapeutics
Nov 10, 2023
Upgrades: Buy
Price Target: $18 → $26
Current: $42.74
Upside: -39.17%